Evidence map›Paper›PMID 39364269›Full record

ArticleAperture neuro2024

Stable multivariate lesion symptom mapping.

Alex Teghipco, Roger Newman-Norlund, Makayla Gibson, Leonardo Bonilha, John Absher, Julius Fridriksson, Christopher Rorden

Abstract read
In one paragraph

Article in Aperture neuro, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alex TeghipcoCommunication Sciences & Disorders, University of South Carolina.
Roger Newman-NorlundPsychology, University of South Carolina.
Makayla GibsonPsychology, University of South Carolina.
Leonardo BonilhaCommunication Sciences & Disorders, University of South Carolina.
John AbsherNeurology, University of South Carolina School of Medicine.
Julius FridrikssonCommunication Sciences & Disorders, University of South Carolina.
Christopher RordenPsychology, University of South Carolina.

Funding

Telerehab for Aphasia (TERRA)P50DC014664 · NIDCD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FRIDRIKSSON, JULIUS · 2016 to 2025
$25.0M
Extending ezBIDS, NiiVue and dcm2niix for user-friendly cloud-based integration and visualizationRF1MH133701 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI RORDEN, CHRISTOPHER · 2023 to 2023
$2.0M
Neural Predictors of Anomia Recovery in AphasiaR01DC008355 · NIDCD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FRIDRIKSSON, JULIUS · 2007 to 2011
$1.7M
NIDCD NIH HHS P50 DC014664NIDCD NIH HHS R01 DC008355NIMH NIH HHS RF1 MH133701
6 · The paper itself

Abstract

Multivariate lesion-symptom mapping (MLSM) considers lesion information across the entire brain to predict impairments. The strength of this approach is also its weakness-considering many brain features together synergistically can uncover complex brain-behavior relationships but exposes a high-dimensional feature space that a model is expected to learn. Successfully distinguishing between features in this landscape can be difficult for models, particularly in the presence of irrelevant or redundant features. Here, we propose stable multivariate lesion-symptom mapping (sMLSM), which integrates the identification of reliable features with stability selection into conventional MLSM and describe our open-source MATLAB implementation. Usage is showcased with our publicly available dataset of chronic stroke survivors (N=167) and further validated in our independent public acute stroke dataset (N = 1106). We demonstrate that sMLSM eliminates inconsistent features highlighted by MLSM, reduces variation in feature weights, enables the model to learn more complex patterns of brain damage, and improves model accuracy for predicting aphasia severity in a way that tends to be robust regarding the choice of parameters for identifying reliable features. Critically, sMLSM more consistently outperforms predictions based on lesion size alone. This advantage is evident starting at modest sample sizes (N>75). Spatial distribution of feature importance is different in sMLSM, which highlights the features identified by univariate lesion symptom mapping while also implicating select regions emphasized by MLSM. Beyond improved prediction accuracy, sMLSM can offer deeper insight into reliable biomarkers of impairment, informing our understanding of neurobiology.

Identifiers

PMID39364269
PMCPMC11449259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.